|
1
|
DePaul MA, Palmer M, Lang BT, Cutrone R,
Tran AP, Madalena KM, Bogaerts A, Hamilton JA, Deans RJ and Mays
RW: Intravenous multipotent adult progenitor cell treatment
decreases inflammation leading to functional recovery following
spinal cord injury. Sci Rep. 5:167952015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Amemori T, Ruzicka J, Romanyuk N,
Jhanwar-Uniyal M, Sykova E and Jendelova P: Comparison of
intraspinal and intrathecal implantation of induced pluripotent
stem cell-derived neural precursors for the treatment of spinal
cord injury in rats. Stem Cell Res Ther. 6:2572015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Khayrullina G, Bermudez S and Byrnes KR:
Inhibition of NOX2 reduces locomotor impairment, inflammation, and
oxidative stress after spinal cord injury. J Neuroinflammation.
12:1722015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen G, Park CK, Xie RG and Ji RR:
Intrathecal bone marrow stromal cells inhibit neuropathic pain via
TGF-β secretion. J Clin Invest. 125:3226–3240. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jahan N and Hannila SS: Transforming
growth factor β-induced expression of chondroitin sulfate
proteoglycans is mediated through non-Smad signaling pathways. Exp
Neurol. 263:372–384. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Heise RL, Parekh A, Joyce EM, Chancellor
MB and Sacks MS: Strain history and TGF-β1 induce urinary bladder
wall smooth muscle remodeling and elastogenesis. Biomech Model
Mechanobiol. 11:131–145. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Quinlan JF, Watson RW, Kelly G, Kelly PM,
O'Byrne JM and Fitzpatrick JM: Transforming growth factor-beta
(TGF-beta) in acute injuries of the spinal cord. J Bone Joint Surg
Br. 88:406–410. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mao L, Wang HD, Wang XL, Tian L and Xu JY:
Disruption of Nrf2 exacerbated the damage after spinal cord injury
in mice. J Trauma Acute Care Surg. 72:189–198. 2012.PubMed/NCBI
|
|
9
|
Wang C, Wang P, Zeng W and Li W:
Tetramethylpyrazine improves the recovery of spinal cord injury via
Akt/Nrf2/HO-1 pathway. Bioorg Med Chem Lett. 26:1287–1291. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hirakawa A, Shimizu K, Fukumitsu H and
Furukawa S: Pyrroloquinoline quinone attenuates iNOS gene
expression in the injured spinal cord. Biochem Biophys Res Commun.
378:308–312. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Song Y, Liu J, Zhang F, Zhang J, Shi T and
Zeng Z: Antioxidant effect of quercetin against acute spinal cord
injury in rats and its correlation with the p38MAPK/iNOS signaling
pathway. Life Sci. 92:1215–1221. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lin CC, Chiang TH, Chen WJ, Sun YY, Lee YH
and Lin MS: CISD2 serves a novel role as a suppressor of nitric
oxide signalling and curcumin increases CISD2 expression in spinal
cord injuries. Injury. 46:2341–2350. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lorenz P, Roychowdhury S, Engelmann M,
Wolf G and Horn TF: Oxyresveratrol and resveratrol are potent
antioxidants and free radical scavengers: Effect on nitrosative and
oxidative stress derived from microglial cells. Nitric Oxide.
9:64–76. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee HS, Kim DH, Hong JE, Lee JY and Kim
EJ: Oxyresveratrol suppresses lipopolysaccharide-induced
inflammatory responses in murine macrophages. Hum Exp Toxicol.
34:808–818. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Andrabi SA, Spina MG, Lorenz P, Ebmeyer U,
Wolf G and Horn TF: Oxyresveratrol
(trans-2,3′,4,5′-tetrahydroxystilbene) is neuroprotective and
inhibits the apoptotic cell death in transient cerebral ischemia.
Brain Res. 1017:98–107. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Weber JT, Lamont M, Chibrikova L, Fekkes
D, Vlug AS, Lorenz P, Kreutzmann P and Slemmer JE: Potential
neuroprotective effects of oxyresveratrol against traumatic injury.
Eur J Pharmacol. 680:55–62. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sasivimolphan P, Lipipun V, Ritthidej G,
Chitphet K, Yoshida Y, Daikoku T, Sritularak B, Likhitwitayawuid K,
Pramyothin P, Hattori M and Shiraki K: Microemulsion-based
oxyresveratrol for topical treatment of herpes simplex virus (HSV)
infection: Physicochemical properties and efficacy in cutaneous
HSV-1 infection in mice. AAPS Pharm Sci Tech. 13:1266–1275. 2012.
View Article : Google Scholar
|
|
18
|
Wang W, Shen H, Xie JJ, Ling J and Lu H:
Neuroprotective effect of ginseng against spinal cord injury
induced oxidative stress and inflammatory responses. Int J Clin Exp
Med. 8:3514–3521. 2015.PubMed/NCBI
|
|
19
|
Min SH, Soh JS, Park JY, Choi SU, Lee HW,
Lee JJ and Kim JH: Epidural dexamethasone decreased inflammatory
hyperalgesia and spinal cPLA2 expression in a rat formalin test.
Yonsei Med J. 55:1631–1639. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Stammers AT, Liu J and Kwon BK: Expression
of inflammatory cytokines following acute spinal cord injury in a
rodent model. J Neurosci Res. 90:782–790. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Han D, Wu C, Xiong Q, Zhou L and Tian Y:
Anti-inflammatory mechanism of bone marrow mesenchymal stem cell
transplantation in rat model of spinal cord injury. Cell Biochem
Biophys. 71:1341–1347. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
López-Vales R, García-Alías G,
Guzmán-Lenis MS, Forés J, Casas C, Navarro X and Verdú E: Effects
of COX-2 and iNOS inhibitors alone or in combination with olfactory
ensheathing cell grafts after spinal cord injury. Spine (Phila Pa
1976). 31:1100–1106. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ashraf MI, Shahzad M and Shabbir A:
Oxyresveratrol ameliorates allergic airway inflammation via
attenuation of IL-4, IL-5, and IL-13 expression levels. Cytokine.
76:375–381. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hayashi K, Ohta S, Kawakami Y and Toda M:
Activation of dendritic-like cells and neural stem/progenitor cells
in injured spinal cord by GM-CSF. Neurosci Res. 64:96–103. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Watanabe S, Uchida K, Nakajima H, Matsuo
H, Sugita D, Yoshida A, Honjoh K, Johnson WE and Baba H: Early
transplantation of mesenchymal stem cells after spinal cord injury
relieves pain hypersensitivity through suppression of pain-related
signaling cascades and reduced inflammatory cell recruitment. Stem
Cells. 33:1902–1914. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chung J, Kim MH, Yoon YJ, Kim KH, Park SR
and Choi BH: Effects of granulocyte colony-stimulating factor and
granulocyte-macrophage colony-stimulating factor on glial scar
formation after spinal cord injury in rats. J Neurosurg Spine.
21:966–973. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Quan HH, Kang KS, Sohn YK and Li M: Tempol
reduces injury area in rat model of spinal cord contusion injury
through suppression of iNOS and COX-2 expression. Neurol Sci.
34:1621–1628. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Song HX, Scarpatetti M, Kreil W, Shen HL,
Bodo K, Ebner B, Schröttner H and Mokry M: Quantitative analysis of
cyclooxygenase 2 in the posterior longitudinal ligament of cervical
spondylotic myelopathy. Chin Med J (Engl). 124:2480–2484.
2011.PubMed/NCBI
|
|
29
|
Kanninen KM, Pomeshchik Y, Leinonen H,
Malm T, Koistinaho J and Levonen AL: Applications of the Keap1-Nrf2
system for gene and cell therapy. Free Radic Biol Med. 88:350–361.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang X, Campos CR, Peart JC, Smith LK,
Boni JL, Cannon RE and Miller DS: Nrf2 upregulates ATP binding
cassette transporter expression and activity at the blood-brain and
blood-spinal cord barriers. J Neurosci. 34:8585–8593. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Miller DM, Singh IN, Wang JA and Hall ED:
Nrf2-ARE activator carnosic acid decreases mitochondrial
dysfunction, oxidative damage and neuronal cytoskeletal degradation
following traumatic brain injury in mice. Exp Neurol. 264:103–110.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Choi HY, Lee JH, Jegal KH, Cho IJ, Kim YW
and Kim SC: Oxyresveratrol abrogates oxidative stress by activating
ERK-Nrf2 pathway in the liver. Chem Biol Interact. 245:110–121.
2016. View Article : Google Scholar : PubMed/NCBI
|
